Gain Therapeutics Inc (GANX) — Financial Flexibility Index
Gain Therapeutics Inc (GANX) has a Financial Flexibility Index of -1.09x as of December 2025. Free cash flow of $-4.62 Million (operating CF $-4.62 Million minus capex $3.00) represents -1% of total liabilities ($4.25 Million). Check Gain Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gain Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Gain Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see GANX cash flow metrics.
Annual Financial Flexibility Index for Gain Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Gain Therapeutics Inc. Explore Gain Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.34x | $-18.47 Million | $-18.47 Million | $4.25 Million | ▼ -10.2% |
| 2024 | -3.94x | $-18.85 Million | $-18.87 Million | $4.78 Million | ▼ -26.1% |
| 2023 | -3.13x | $-18.85 Million | $-18.87 Million | $6.03 Million | ▼ -12.0% |
| 2022 | -2.79x | $-14.57 Million | $-14.69 Million | $5.22 Million | ▲ +5.2% |
| 2021 | -2.94x | $-12.27 Million | $-12.37 Million | $4.17 Million | ▼ -211.2% |
| 2020 | -0.95x | $-3.22 Million | $-3.24 Million | $3.40 Million | ▲ +43.4% |
| 2019 | -1.67x | $-1.85 Million | $-1.87 Million | $1.11 Million | ▼ -299.8% |
| 2018 | -0.42x | $-736.53K | $-744.51K | $1.76 Million | — |